Abeona Therapeutics Net Income 2010-2022 | ABEO

Abeona Therapeutics net income from 2010 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Abeona Therapeutics Annual Net Income
(Millions of US $)
2021 $-85
2020 $-84
2019 $-76
2018 $-57
2017 $-27
2016 $-22
2015 $-15
2014 $-30
2013 $2
2012 $-13
2011 $-4
2010 $-9
2009 $-19
Abeona Therapeutics Quarterly Net Income
(Millions of US $)
2022-03-31 $-21
2021-12-31 $-47
2021-09-30 $-7
2021-06-30 $-15
2021-03-31 $-16
2020-12-31 $-16
2020-09-30 $-7
2020-06-30 $-13
2020-03-31 $-48
2019-12-31 $-16
2019-09-30 $-17
2019-06-30 $-24
2019-03-31 $-19
2018-12-31 $-17
2018-09-30 $-16
2018-06-30 $-12
2018-03-31 $-11
2017-12-31 $-8
2017-09-30 $-5
2017-06-30 $-8
2017-03-31 $-5
2016-12-31 $-7
2016-09-30 $-3
2016-06-30 $-7
2016-03-31 $-6
2015-12-31 $-2
2015-09-30 $-6
2015-06-30 $-4
2015-03-31 $-2
2014-12-31 $-13
2014-09-30 $-2
2014-06-30 $-13
2014-03-31 $-2
2013-12-31 $-2
2013-09-30 $-1
2013-06-30 $1
2013-03-31 $3
2012-12-31 $19
2012-09-30 $-15
2012-06-30 $-11
2012-03-31 $-5
2011-12-31 $-0
2011-09-30 $-0
2011-06-30 $-2
2011-03-31 $-2
2010-12-31 $2
2010-09-30 $-13
2010-06-30 $1
2010-03-31 $1
2009-12-31 $-9
2009-09-30 $-5
2009-06-30 $-3
2009-03-31 $-3
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.023B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $165.194B 10.05
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.361B 16.35
Biohaven Pharmaceutical Holding (BHVN) United States $10.098B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.208B 0.00
Emergent Biosolutions (EBS) United States $1.617B 6.92
Arcus Biosciences (RCUS) United States $1.305B 33.09
Myovant Sciences (MYOV) United Kingdom $0.956B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.500B 0.00
Zymeworks (ZYME) Canada $0.368B 0.00
Gelesis Holdings (GLS) United States $0.349B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.108B 22.10
SQZ Biotechnologies (SQZ) United States $0.097B 0.00